top
Breakthrough ovarian cancer drug offers patients more time and better quality of life
Key takeaways
- Patricia Hill Patricia says the drug has enabled her to go to the theatre and visit family.
- The drug, called mirvetuximab soravtansine, is a known as a "biological missile" as it delivers chemotherapy drugs direct to the cancerous tissue rather than to the whole body - reducing debilitating side-effects.
- Patricia Hill, 64, said the treatment was allowing her to do things – like visiting family and going to the theatre - that were impossible on conventional chemotherapy.
Why this matters: a developing story that could shape the day's news cycle.
Patricia Hill Patricia says the drug has enabled her to go to the theatre and visit family. A breakthrough drug for ovarian cancer that is kinder on the body and extends lives is now available on the NHS.
The drug, called mirvetuximab soravtansine, is a known as a "biological missile" as it delivers chemotherapy drugs direct to the cancerous tissue rather than to the whole body - reducing debilitating side-effects.
Patricia Hill, 64, said the treatment was allowing her to do things – like visiting family and going to the theatre - that were impossible on conventional chemotherapy.
Article preview — originally published by BBC News. Full story at the source.
Read full story on BBC News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from BBC News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop